Why did two private equity firms with more than $460 billion under management want a little old gene therapy biotech called ...

The women’s health focused company acquired the drug for up to $954 million in 2021 through the acquisition of Forendo Pharma ...

The safety update for Vyvgart rattled argenx’s shares on Monday, a reaction that analysts at William Blair said was “overdone ...

Kennedy wants to expand the injury compensation program to include COVID-19 vaccines, while also stretching the “statute of ...

As an office of the executive branch, the Department of Health and Human Services “does not have the authority” to implement ...